NASDAQ · AIDX
20/20 Biolabs, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for AIDX: Nov 13, 2026
20/20 Biolabs, Inc. Common Stock is estimated to report earnings on 11/13/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Fintel- RTTNews · Aug 17, 1:54 PM EDTBioLabs Reports Q2 Revenue Growth; OneTest Cancer Revenue Climbs 47%(RTTNews) – 20/20 BioLabs, Inc. (AIDX), an AI-powered diagnostics company focused on early cancer and chronic disease detection, reported second-quarter 2026 results, with OneTest revenue rising 47% year over year and gross margin expanding significantly.
- RTTNews · May 29, 10:39 AM EDTWeekly Buzz: AZN, JNJ Get FDA Nod; LLY To Acquire Curevo; APGE Advances Zumilokibart(RTTNews) – This week in the biotech space, there were regulatory approvals across the U.S. and Europe, collaborations, acquisitions, and positive data readouts spanning multiple therapeutic areas, including primary biliary cholangitis, fatigue, resectable lung cancer, and modera
- RTTNews · May 27, 11:29 AM EDT20/20 Biolabs Secures Vermont Statewide Firefighter Cancer Screening Deal But Stock Down(RTTNews) – 20/20 Biolabs, Inc. (AIDX), which develops AI-powered laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, announced that its OneTest multi-cancer early detection blood test has been selected by the state of Vermont for
- RTTNews · May 26, 6:01 AM EDT20/20 Biolabs Initiates Emergency Lab Testing Plans For Ebola And Hantavirus If Outbreak Arises(RTTNews) – 20/20 Biolabs, Inc. (AIDX), a diagnostic firm focused on laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, announced that it is developing contingency plans to potentially support Ebola and Hantavirus PCR testing in i
- RTTNews · May 21, 3:39 AM EDT20/20 BioLabs Q1 Revenue Slips; Eyes Q2 Growth From Maryland Firefighter Cancer Screening Program(RTTNews) – 20/20 BioLabs, Inc. (AIDX) reported its financial results for the first quarter, reflecting a revenue slip for the period ending March 31, 2026.
- Fintel · May 11, 8:04 PM EDTMaxim Group Initiates Coverage of 20 (AIDX) with Buy RecommendationFintel reports that on May 11, 2026, Maxim Group initiated coverage of 20 (NasdaqCM:AIDX) with a Buy recommendation. What is the Fund Sentiment?
- RTTNews · Mar 25, 8:05 AM EDT20/20 BioLabs Secure U.S. License For Advanced CKD Prediction Technology(RTTNews) – 20/20 BioLabs, Inc., (AIDX) is strengthening its position in the fast-growing longevity analytics space after securing an exclusive U.S. license to integrate ROKIT Healthcare's chronic kidney disease (CKD) prediction algorithm into its OneTest for Longevity platform-
- RTTNews · Feb 25, 11:07 AM EST20/20 BioLabs Stock Falls 27% As Company Launches Longevity Blood Test(RTTNews) – 20/20 BioLabs (AIDX), an AI-powered diagnostic company, announced the launch of its OneTest for Longevity, a blood test designed to assess chronic disease risk and support personalized health management.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for 20/20 Biolabs, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.